Abstract
Background As control efforts progress towards elimination, malaria is likely to become more spatially concentrated in few local areas. The purpose of this study was to quantify and characterise spatial heterogeneity in malaria transmission-intensity across highly endemic Indonesian Papua.
Methods We analysed individual-level malaria surveillance data for nearly half a million cases (2019–2020) reported in the Papua and West Papua provinces and adapted the Gini index approach to quantify spatial heterogeneity at the district and health-unit levels. We showed malaria incidence trends and the spatial and temporal distribution of sociodemographic characteristics and aetiological parasites among cases.
Findings While Papua province accounted for the majority of malaria cases reported in the region and had seen a rise in transmission since 2015, West Papua province had maintained a comparatively low incidence. We observed that Gini index estimates were high, particularly when the lower spatial scale of health units was evaluated. The Gini index appears to be inversely associated to annual parasite-incidence, as well as the proportions of vivax malaria, male sex, and adults.
Interpretation This study suggests that areas with varying levels of transmission-intensities exhibited distinct characteristics. Malaria was distributed in a markedly disproportionate manner throughout the region, emphasising the need for spatially targeted interventions. Periodic quantification and characterisation of risk heterogeneity at various spatial levels using routine malaria surveillance data may aid in tracking progress towards elimination and guiding evidence-informed prioritisation of resource allocation.
Funding Strengthening Preparedness in the Asia-Pacific Region through Knowledge (SPARK) project.
Evidence before this study We searched PubMed up to and including November 19, 2021, for relevant articles on the spatial distribution of malaria in the Papua region of Indonesia, using the terms (“malaria”) AND (“distribution” OR “variation” OR “heterogeneity” OR “cluster” OR “aggregation”) AND (“Papua”) AND (“Indonesia”). Despite the region’s mostly stable transmission areas, there has been considerable variation in transmission intensity across the region. According to community surveys conducted up to 2010, estimates of parasite prevalence of Plasmodium falciparum and Plasmodium vivax were highly variable, ranging from 0% to at least 40% and from 0% to at least 7%, respectively, across the region. Similarly, when the Papuan subset of the 2007 National Basic Health Research data was used, the degree of spatial heterogeneity in malaria risk among Papuan districts remained apparent even after sociodemographic were adjusted. Current evidence that is more representative of the current situation, including an easily interpretable and comparable measure of spatial heterogeneity across space and time, is limited.
Added value of this study Our analysis of large-scale and routinely collected malaria surveillance data from January 2019 to December 2020 revealed significant spatial heterogeneity across the Papua region, as measured by the Gini index. Complementing conventional approaches using geospatial maps and risk tables, the Gini index can be used to provide a single, and sensitive numerical indicator summarising the degree of transmission heterogeneity at a specified spatial level of interest. Along with the previously recognised high spatial heterogeneity among districts, this study revealed a greater degree of intra-district heterogeneity at the health-unit level. That is, within the districts, there were also few health centres and hospitals with a disproportionately higher malaria burden. We observed distinct characteristics of individuals who contracted malaria in districts with varying levels of incidence. The higher transmission magnitude was associated with a lower Gini index, as well as with lower proportions of vivax malaria, male sex, and adults among the cases.
Implications of all the available evidence This study provides contemporary empirical evidence for the spatial heterogeneity of malaria distribution across the Papua region of Indonesia, particularly at the lower spatial resolution of health units. Evaluating spatial heterogeneity at a lower spatial scale is likely essential to refine and update local malaria control strategic planning. The combination of comprehensive, routine malaria surveillance data and the Gini index may enable policymakers to assess the magnitude and characteristics of spatial heterogeneity with increased frequency, interpretability, and comparability, allowing for the rapid identification of transmission foci and the deployment of public health measures. Effective control of parasite reservoirs associated with intense transmission may further shrink the risk of infection in adjacent areas with a lower degree of malaria exposure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Strengthening Preparedness in the Asia-Pacific Region through Knowledge (SPARK) project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the National Institute of Health Research and Development, Ministry of Health, Indonesia (LB.02.01/2/KE.534/2021) gave ethical approval for this work. Informed consent from patients included in these anonymised data was waived due to the secondary nature of these routine surveillance data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author details
Eijkman-Oxford Clinical Research Unit Jalan Diponegoro 69, Jakarta Pusat 10430, Indonesia
Ihsan Fadilah, MSc ifadilah{at}eocru.org
Henry Surendra, PhD hsurendra{at}eocru.org
Karina D. Lestari, BSc kdlestari{at}eocru.org
Lenny L. Ekawati, MPH lekawati{at}eocru.org
Rahmat Sagara, MSc rsagara{at}eocru.org
Rosa N. Lina, MSc rlina{at}eocru.org
Prof J. Kevin Baird, PhD kbaird{at}eocru.org
Iqbal R. F. Elyazar, DPhil ielyazar{at}eocru.org
Department of Infectious Disease Epidemiology, Imperial College London St Mary’s Campus, Norfolk Place, London W2 1PG, United Kingdom
Bimandra A. Djaafara, MSc bimandra.djaafara15{at}imperial.ac.uk
Sub-Directorate for Malaria Control, Ministry of Health Jalan H. R. Rasuna Said Blok X 5 Kav. 4-9, Jakarta Selatan 12950, Indonesia
Guntur Argana, MD subditmalaria_kemenkes{at}yahoo.co.id
Desriana E. Ginting, MD subditmalaria_kemenkes{at}yahoo.co.id
Sri Budi Fajariyani, BSc subditmalaria_kemenkes{at}yahoo.co.id
West Papua Provincial Health Office Jalan Brigjen Marinir (Purn) Abraham O. Atururi, Arfai, Manokwari 98315, Papua Barat, Indonesia
Edi Sunandar, MSc ediis_75{at}yahoo.com
Billy Graham Makamur, BSc billygraham1643{at}gmail.com
Papua Provincial Health Office Jalan Raya Abepura, Kotaraja, Jayapura 99225, Papua, Indonesia
Berry Wopari, MD gfmalariapapua{at}yahoo.co.id
Silas Mabui, MSc gfmalariapapua{at}yahoo.co.id
UNICEF Indonesia Country Office Jalan Sudirman Kav. 31, Wisma Metropolitan II, FI 10 th, 12920, Jakarta, Indonesia
Maria Endang Sumiwi, MD msumiwi{at}unicef.org
Ferdinand J. Laihad, MD laihad{at}centrin.net.id
Division of Population Health and Immunity, Walter and Eliza Hall Institute 1G Royal Parade, Parkville Victoria 3052, Australia
Prof Ivo Mueller, PhD mueller{at}wehi.edu.au
Peter Doherty Institute for Infection and Immunity, University of Melbourne 792 Elizabeth Street, Melbourne 3000, Australia
Prof Jodie McVernon, PhD j.mcvernon{at}unimelb.edu.au
Data Availability
The datasets supporting the conclusions of this study can be accessed at http://www.sismal.malaria.id/ (available upon request to the Indonesian Sub-Directorate for Malaria Control), https://www.bps.go.id/ (publicly available), and http://bppsdmk.kemkes.go.id/web/ (publicly available) for the individual-level malaria surveillance data, the projected population sizes, and the numbers of health units in the Papua region, respectively.
